共 110 条
- [1] AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus [J]. NATURE COMMUNICATIONS, 2018, 9
- [3] Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07): : 1920 - 1928
- [4] Baumgarten R, 1998, J AM SOC NEPHROL, V9, P1553
- [5] Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (01): : 232 - 243
- [7] Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology [J]. CLINICAL KIDNEY JOURNAL, 2012, 5 (03): : 195 - 202
- [9] Calcitonin Has a Vasopressin-like Effect on Aquaporin-2 Trafficking and Urinary Concentration [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (01): : 59 - 72